ORIC Pharmaceuticals Inc. (ORIC)
7.66
-0.37 (-4.61%)
At close: Mar 03, 2025, 3:59 PM
7.64
-0.26%
After-hours: Mar 03, 2025, 04:00 PM EST
ORIC Pharmaceuticals Balance Sheet Statement
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Cash & Equivalents | 59.41M | 23.38M | 66.84M | 226.01M | 78.45M | 89.16M | 42.64M | 25.82M |
Short-Term Investments | 196.55M | 184.8M | 139.43M | 10.97M | 215.15M | n/a | n/a | n/a |
Long-Term Investments | n/a | 26.85M | 21.95M | 43.39M | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 8.97M | 552K | 11.52M | 12.32M | 319K | 1.85M | 496K | 513K |
Receivables | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | 6.29M | 4.41M | 4.18M | 7.09M | 6.19M | 840K | 1.09M | 791K |
Total Current Assets | 262.25M | 212.6M | 210.46M | 240.52M | 296.7M | 90M | 43.72M | 26.61M |
Property-Plant & Equipment | 2.92M | 12.01M | 3.25M | 2.41M | 1.98M | 2.24M | 2.51M | 2.9M |
Goodwill & Intangibles | n/a | n/a | -3.18M | -3.41M | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 11.89M | 39.41M | 36.72M | 58.12M | 2.3M | 4.09M | 3.01M | 3.41M |
Total Assets | 274.14M | 252.01M | 247.18M | 298.64M | 299M | 94.09M | 46.73M | 30.02M |
Account Payables | 1.55M | 944K | 1.32M | 1.89M | 757K | 152K | 446K | 940K |
Deferred Revenue | n/a | n/a | n/a | n/a | 546K | 495K | 438K | 388K |
Short-Term Debt | n/a | 2.75M | 2.66M | 1.93M | n/a | n/a | n/a | n/a |
Other Current Liabilities | 23.3M | 16.76M | 11.41M | 11.34M | 8.24M | 4.71M | 1.71M | 1.28M |
Total Current Liabilities | 24.85M | 20.46M | 15.39M | 15.15M | 9M | 5.35M | 2.6M | 2.61M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 6.17M | 7.46M | 9.44M | 10.52M | 219K | n/a | 107.31M | n/a |
Total Long-Term Liabilities | 6.17M | 7.46M | 9.44M | 10.52M | 219K | 765K | 108.56M | 1.69M |
Total Liabilities | 31.02M | 27.92M | 24.83M | 25.67M | 9.22M | 6.12M | 111.16M | 4.3M |
Total Debt | 3.18M | 10.21M | 2.66M | 1.93M | n/a | n/a | n/a | n/a |
Common Stock | 7K | 6K | 5K | 4K | 4K | 2K | 1K | 1K |
Retained Earnings | -562.77M | -434.93M | -334.23M | -245.11M | -166.39M | -92.69M | -65.81M | -44.44M |
Comprehensive Income | 379K | 258K | -1.29M | -103K | -31K | -178.06M | -2.58M | 0.00 |
Shareholders Equity | 243.12M | 224.09M | 222.35M | 272.98M | 289.78M | 87.97M | -64.43M | 25.73M |
Total Investments | 196.55M | 211.66M | 161.38M | 54.36M | 215.15M | n/a | n/a | n/a |